Sarbanes-Oxley Act of 2002 (Sarbanes-Oxley) requires that GSK's Annual Report contains a statement as to whether a member of the company's Audit & Risk Committee is an “Audit Committee Financial Expert” as defined by Sarbanes-Oxley. A consistent approach is taken by the Board in respect of this requirement and a similar requirement in the UK Corporate Governance Code for a member of the Audit & Risk Committee to have “recent and relevant financial experience”. The Board has determined that Tom de Swann, Audit & Risk Committee Chairman, has the appropriate qualifications and background to be an “Audit Committee Financial Expert” and also has “recent and relevant financial experience”.